Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Sep 30, 2016 | $35.0B |
| FY2017, ended Sep 30, 2017 | $40.3B |
| FY2018, ended Sep 30, 2018 | $48.0B |
| FY2019, ended Sep 30, 2019 | $40.7B |
| FY2020, ended Sep 30, 2020 | $39.2B |
| FY2021, ended Sep 30, 2021 | $56.0B |
| FY2022, ended Sep 30, 2022 | $43.3B |
| FY2023, ended Sep 30, 2023 | $55.1B |
| FY2024, ended Sep 30, 2024 | $62.4B |
| FY2025, ended Sep 30, 2025 | $73.7B |
| Trailing 12 months to Jun 30, 2026 (through Q3 FY2026) | $79.8B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Sep 30, 2016 | $14.5B |
| FY2017, ended Sep 30, 2017 | $15.3B |
| FY2018, ended Sep 30, 2018 | $17.4B |
| FY2019, ended Sep 30, 2019 | $18.4B |
| FY2020, ended Sep 30, 2020 | $16.8B |
| FY2021, ended Sep 30, 2021 | $12.9B |
| FY2022, ended Sep 30, 2022 | $13.8B |
| FY2023, ended Sep 30, 2023 | $15.2B |
| FY2024, ended Sep 30, 2024 | $17.5B |
| FY2025, ended Sep 30, 2025 | $18.0B |
| Trailing 12 months to Jun 30, 2026 (through Q3 FY2026) | $18.6B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Sep 30, 2016 | $1.64B | $2.43B |
| FY2017, ended Sep 30, 2017 | $1.52B | $1.44B |
| FY2018, ended Sep 30, 2018 | $2.20B | $2.27B |
| FY2019, ended Sep 30, 2019 | $2.31B | $2.41B |
| FY2020, ended Sep 30, 2020 | $1.97B | $2.54B |
| FY2021, ended Sep 30, 2021 | $2.30B | $3.17B |
| FY2022, ended Sep 30, 2022 | $3.23B | $2.62B |
| FY2023, ended Sep 30, 2023 | $13.2B | $274M |
| FY2024, ended Sep 30, 2024 | $1.97B | $2.91B |
| FY2025, ended Sep 30, 2025 | $2.29B | $2.67B |
| Trailing 12 months to Jun 30, 2026 (through Q3 FY2026) | $2.58B | $3.46B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Sep 30, 2016 | $3.18B |
| FY2017, ended Sep 30, 2017 | $3.06B |
| FY2018, ended Sep 30, 2018 | $1.09B |
| FY2019, ended Sep 30, 2019 | $1.49B |
| FY2020, ended Sep 30, 2020 | $3.31B |
| FY2021, ended Sep 30, 2021 | $2.35B |
| FY2022, ended Sep 30, 2022 | $1.80B |
| FY2023, ended Sep 30, 2023 | $8.05B |
| FY2024, ended Sep 30, 2024 | $3.59B |
| FY2025, ended Sep 30, 2025 | $1.54B |
| Trailing 12 months to Jun 30, 2026 (through Q3 FY2026) | $2.18B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Sep 30, 2016 | $6.63B |
| FY2017, ended Sep 30, 2017 | $4.66B |
| FY2018, ended Sep 30, 2018 | $4.76B |
| FY2019, ended Sep 30, 2019 | $5.72B |
| FY2020, ended Sep 30, 2020 | $7.49B |
| FY2021, ended Sep 30, 2021 | $6.67B |
| FY2022, ended Sep 30, 2022 | $10.4B |
| FY2023, ended Sep 30, 2023 | $8.16B |
| FY2024, ended Sep 30, 2024 | $7.69B |
| FY2025, ended Sep 30, 2025 | $13.1B |
| Trailing 12 months to Jun 30, 2026 (through Q3 FY2026) | $13.1B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 13.2% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Sep 30, 2016 | 643M |
| FY2017, ended Sep 30, 2017 | 642M |
| FY2018, ended Sep 30, 2018 | 626M |
| FY2019, ended Sep 30, 2019 | 609M |
| FY2020, ended Sep 30, 2020 | 598M |
| FY2021, ended Sep 30, 2021 | 595M |
| FY2022, ended Sep 30, 2022 | 591M |
| FY2023, ended Sep 30, 2023 | 570M |
| FY2024, ended Sep 30, 2024 | 570M |
| FY2025, ended Sep 30, 2025 | 562M |
| Trailing 12 months to Jun 30, 2026 (through Q3 FY2026) | 558M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Sep 30, 2016 | $601M | $145M |
| FY2017, ended Sep 30, 2017 | $400M | $110M |
| FY2018, ended Sep 30, 2018 | $1.00B | $216M |
| FY2019, ended Sep 30, 2019 | $1.25B | $120M |
| FY2020, ended Sep 30, 2020 | $942M | $110M |
| FY2021, ended Sep 30, 2021 | $500M | $197M |
| FY2022, ended Sep 30, 2022 | $500M | $125M |
| FY2023, ended Sep 30, 2023 | $2.00B | $250M |
| FY2024, ended Sep 30, 2024 | $435M | $260M |
| FY2025, ended Sep 30, 2025 | $1.17B | $263M |
| Trailing 12 months to Jun 30, 2026 (through Q3 FY2026) | $918M | $246M |
Valuation
At current price- Market Cap
- $92.7B
- P/E
- 36.0×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 5.0×
- Price / Book
- 4.6×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $18.6B
- Revenue Growth YoY
- 4.8%
- Revenue CAGR 3Y
- 9.3%
- Revenue CAGR 5Y
- 1.4%
- EPS Growth YoY
- −1.9%
- Net Income Growth YoY
- −2.9%
Profitability
Trailing 12 months- Gross Margin
- 53.2%
- Operating Margin
- —
- Net Margin
- 13.8%
- FCF Margin
- 18.6%
- Return on Equity
- 12.8%
Earnings
Trailing 12 months- Net Income
- $2.58B
- EPS (diluted)
- $4.57
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $2.18B
- Total Debt
- $13.1B
- Net Debt
- $10.9B
- Total Assets
- $42.2B
- Total Liabilities
- $21.8B
- Shareholders' Equity
- $20.4B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $3.91B
- Capital Expenditure
- $452M
- Free Cash Flow
- $3.46B
Dividends and risk
Last 12 months- Dividend Yield
- 1.3%
- Dividend / Share
- $2.22
- Beta (5Y)
- 1.21
Every ratio is calculated from the company’s reported figures.